期刊文献+

急性混合细胞白血病44例的临床诊治分析 被引量:8

下载PDF
导出
摘要 目的:分析急性混合细胞白血病(biphenotypic acute leukemia,HAL)的临床和实验室特征以及治疗和预后。方法:根据骨髓细胞形态学、免疫表型、细胞遗传学和分子生物学结果诊断HAL,评价疗效及影响疗效的相关因素。结果:44例HAL临床表现可有发热、淋巴结肿大、脾大、肝大、睾丸浸润等,所有患者骨髓增生明显活跃,近半数患者属高白细胞白血病。进行免疫表型检测者44例,其中B/M双表型33例、T/M双表型10例,B/T型1例。诱导化疗的总体完全缓解(CR)率为32%,34例接受治疗后11例获得CR,有2例巩固强化治疗后持续缓解,中位总生存期(OS)为13个月(3~43个月),1例仅给予淋系和2例仅给予粒系的诱导未达到CR。结论:HAL患者存在着发病年龄偏大,高白细胞、预后不良型染色体改变比例较高。治疗上给予兼顾粒、淋二系的诱导和巩固化疗方案治疗,缓解率高及总生存期长。但长期疗效的评价还有待进一步观察。
出处 《实用医学杂志》 CAS 北大核心 2012年第3期448-450,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献11

  • 1Saikevych I A,Kerrigan D P,McConnell T S,et al.Multiparameter analysis of acute mixed lineage leukemia[J].Leukemia,1991,5(5):373-382. 被引量:1
  • 2Matutes E.The value of c-kit in the diagnosis of biphenotypic acute leukemia of ECIL (European group for the inmunological characterinization of leukemia)[J].Leukemia,1998,12(2):2038-2041. 被引量:1
  • 3王书杰,汪玄,葛昌文,朱铁楠,周道斌,张薇,焦力,赵永强,沈悌.12例急性混合细胞白血病的诊断与疗效分析[J].白血病.淋巴瘤,2005,14(4):201-204. 被引量:18
  • 4张之南,沈悌主编..血液病诊断及疗效标准 第3版[M].北京:科学出版社,2007:271.
  • 5Xianfeng Frank Zhao,Ivana Gojo.Diagnosis of biphenotypic acute leukemia; a paradigmatic approach[J].Int J Clin Exp Pathol,2010,3(1):75-86. 被引量:1
  • 6Owaidah T M,Albeihany A,Iqbal M A,et al.Cytogenetics,molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system[J].Leukemia,2006,20(4):620-626. 被引量:1
  • 7Selle B,Bar C,Hecker S,et al.ABL.specific tyrosine inhibitor imatinibas salvage therapy in a child with Philadelphia chromosome/positive acute mixed lineage leukemia (AMML)[J].Leukemia,2002,16(7):13930-1395. 被引量:1
  • 8Ikegam E K,Mukouchi C,Kunitomi A,et al.Successful treatment of bcr/ab1 positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA haploidentical (3antigenmis matched) cousin[J].Bone Marrow Transplant,2003,31(12):1165-1168. 被引量:1
  • 9Killick S,Matutes E,Powles R L,et al.Outcome of biphenotypicacute leukemia[J].Haematologica,1999,84(8):699-706. 被引量:1
  • 10Legrand O,Perrot J Y,Simonin G,et al.Adult biphenotypic acute leukemia; an entity with poor prognosis which is related to unfavourable cytogenetics and pglycoprotein over expression[J].Br J Haematol,1998,100(1):147. 被引量:1

二级参考文献20

  • 1郭若冰,梁辉,王华.急性混合细胞性白血病临床观察与分析[J].实用医学杂志,2004,20(6):673-674. 被引量:4
  • 2王书杰,汪玄,葛昌文,朱铁楠,周道斌,张薇,焦力,赵永强,沈悌.12例急性混合细胞白血病的诊断与疗效分析[J].白血病.淋巴瘤,2005,14(4):201-204. 被引量:18
  • 3石慧文,赵新民,胡亚美,赵全,李菊.儿童急性混合细胞白血病的临床与实验观察[J].中华血液学杂志,1996,17(1):33-34. 被引量:7
  • 4Pui C H,Raimondi S C,Head D R,et al.Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse[J].Blood,1991,78: 1327-1331. 被引量:1
  • 5Anon E M.The value of c-kit in the diagnosis of biphenotypic acute leukemia of EGIL (European group for the immunological characterization of leukemias)[J].Leukemia,1998,12: 2038-2041. 被引量:1
  • 6Matutes E,Morilla R.Definition of acute biphenotypic leukemia[J].Haematologica,1997,82(1): 64-66. 被引量:1
  • 7Saikevych I A,Kerrigan D P,McConnell T S,et al.Multiparameter analysis of acute mixed lineage leukemia[J].Leukemia,1991,5(5):373-382. 被引量:1
  • 8Cuneo A,Boogaerts M,Ferrant A.Cytogenetics of hybrid acute leukemias[J].Leuk Lymphoma,1995,18 (Suppl 1):19-23. 被引量:1
  • 9Ikegame K,Mukouchi C,Kunitomi A,et al.Successful treatment of bcr/abl-positive acute mixed lineageleukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin[J].Bone Marrow Transplant,2003,31(12):1165-1168. 被引量:1
  • 10Selle B,Bar C,Hecker S,et al.ABL-specific tyrosine inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome -positive acute mixed lineage leukemia (AMML)[J].Leukemia,2002,16(7): 1393 - 1395. 被引量:1

共引文献23

同被引文献48

  • 1郭若冰,梁辉,王华.急性混合细胞性白血病临床观察与分析[J].实用医学杂志,2004,20(6):673-674. 被引量:4
  • 2王鲁群,张明珙,朱平,宋素芹,张洪清,宋强,周越.形态学与免疫学分型不一致的急性白血病基因重排分析[J].中华血液学杂志,1995,16(1):35-36. 被引量:4
  • 3王书杰,汪玄,葛昌文,朱铁楠,周道斌,张薇,焦力,赵永强,沈悌.12例急性混合细胞白血病的诊断与疗效分析[J].白血病.淋巴瘤,2005,14(4):201-204. 被引量:18
  • 4Mawson A R. Retinoids in the treatment of glioma: perspective [J]. Cancer Manag Res, 2012,4:233-241. 被引量:1
  • 5Duong V, Rochette-Egly C. The molecular physiology of nuclear retinoic acid receptors. From health to disease [J]. Biochim Biophys Acta, 2011,1812 (8) : 1023-1031. 被引量:1
  • 6Hyter S, Bajaj G, Liang X, et al. Loss of nuclear receptor RXRa in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas [J]. Pigment Cell Melanoma Res, 2010,23(5) :635-648. 被引量:1
  • 7Connolly R M, Nguyen N K, Sukumar S. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment [J]. Clin Cancer Res,2013,19(7):1651-1659. 被引量:1
  • 8Garattini E, Pamni G, Terao M. Retinoids and breast cancer: new clues to increase their activity and selectivity [J]. Breast Cancer Res, 2012,14(5) : 111. 被引量:1
  • 9Liu Z, Zhou G, Nakamura M, et al. Retinoid X receptor "/ up-regulation is correlated with dedifferentiation of tumor cells and lymph node metastasis in papillary thyroid carcinoma [J]. Pathol Int, 2011,61 (3) : 109-115. 被引量:1
  • 10Christov K. The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer [J]. Curr Cancer Drug Targets, 2009,9(2) : 142-147. 被引量:1

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部